C. Léauté‐Labrèze
- Surgery top 1%
- Neurology top 1%
- Pathology and Forensic Medicine top 1%
- Dermatology top 0.5%
- Oncology top 10%
- Co-authors
- Alain Taı̈ebF. BoraléviKhaled EzzedinePeter H. HoegerJohn HarperS. PreyJ. Mazereeuw‐HautierS. Roul
- Topics
- Vascular Malformations and Hemangiomas (53 papers)Vascular Malformations Diagnosis and Treatment (17 papers)Tumors and Oncological Cases (15 papers)
- Partner nations
- FranceGermanySwitzerland
In The Last Decade
C. Léauté‐Labrèze
117 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Surgery 1.9k
- Neurology 888
- Pathology and Forensic Medicine 785
- Dermatology 719
- Oncology 455
Countries citing papers authored by C. Léauté‐Labrèze
This map shows the geographic impact of C. Léauté‐Labrèze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Léauté‐Labrèze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Léauté‐Labrèze more than expected).
Fields of papers citing papers by C. Léauté‐Labrèze
This network shows the impact of papers produced by C. Léauté‐Labrèze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Léauté‐Labrèze. The network helps show where C. Léauté‐Labrèze may publish in the future.
Co-authorship network of co-authors of C. Léauté‐Labrèze
This figure shows the co-authorship network connecting the top 25 collaborators of C. Léauté‐Labrèze. A scholar is included among the top collaborators of C. Léauté‐Labrèze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Léauté‐Labrèze. C. Léauté‐Labrèze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 7 | |
| 4 | 1 | |
| 5 | 26 | |
| 6 | 6 | |
| 7 | 52 | |
| 8 | 13 | |
| 9 | 41 | |
| 10 | Propranolol for Severe Infantile Hemangiomas: Follow-Up Reportbreakdown → | 399 |
| 11 | 84 | |
| 12 | 74 | |
| 13 | 2 | |
| 14 | 3 | |
| 15 | [Kawasaki's disease with eruptive pustular and guttate psoriasis]. | 11 |
| 16 | 3 | |
| 17 | 7 | |
| 18 | 14 | |
| 19 | Pourquoi les hémangiomes immatures régressent-ils ? | 3 |
| 20 | 5 |
About C. Léauté‐Labrèze
C. Léauté‐Labrèze is a scholar working on Dermatology, Surgery and Neurology, having authored 126 papers that have together received 3.5k indexed citations. Recurring topics across this work include Vascular Malformations and Hemangiomas (53 papers), Vascular Malformations Diagnosis and Treatment (17 papers) and Tumors and Oncological Cases (15 papers). The work is most often cited by research in Dermatology (719 citations), Neurology (888 citations) and Immunology and Allergy (301 citations). C. Léauté‐Labrèze has collaborated with scholars based in France, Germany and Switzerland. Frequent co-authors include Alain Taı̈eb, F. Boralévi, Khaled Ezzedine, Peter H. Hoeger, John Harper, S. Prey, J. Mazereeuw‐Hautier, S. Roul, P Vergnes and Nicolas Grenier. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.